接受近距离放射治疗的宫颈癌患者中的差异
本研究为回顾性队列研究,基于美国国家癌症数据库纳入2004年至2015年初诊时接受放疗的IB2期至IVA期宫颈癌患者25,223例,分析种族和保险状态对近距离放射治疗使用的影响。结果显示非西班牙裔黑人患者接受近距离放射治疗的比例显著低于非西班牙裔白人患者,无保险、医疗补助(Medicaid)和医疗保险(Medicare)患者较私人保险患者更少接受近距离放射治疗;近距离放射治疗未发现是种族和保险相关总生存差异的中介因素。
要点
- 非西班牙裔黑人患者接受近距离放射治疗的比例显著低于非西班牙裔白人患者(OR 0.93;95%CI 0.86-0.99;P=.036)。
- 无保险(OR 0.72;95%CI 0.65-0.79;P<.001)、医疗补助(OR 0.83;95%CI 0.77-0.89;P<.001)和医疗保险(OR 0.85;95%CI 0.78-0.92;P<.001)患者较私人保险患者更少接受近距离放射治疗。
- 近距离放射治疗未发现是种族和保险相关总生存差异的中介因素。
核心结论
- 种族和保险差异存在于接受近距离放射治疗的患者中,许多患者未接受标准治疗,但总生存未受影响。
研究设计与样本
- 回顾性队列研究,基于美国国家癌症数据库,纳入2004年至2015年初诊时接受放疗的IB2期至IVA期宫颈癌患者25,223例。
- 采用单因素分析评估协变量与近距离放射治疗的关联,采用多因素回归模型评估种族和保险状态对近距离放射治疗率的影响。
- 采用Cox比例风险模型和乘法风险模型评估总生存,P<.05表示主要和次要结局比较有统计学显著差异。
主要发现
- 非西班牙裔黑人患者接受近距离放射治疗的比例显著低于非西班牙裔白人患者(OR 0.93;95%CI 0.86-0.99;P=.036)。
- 西班牙裔(OR 0.93;95%CI 0.85-1.02;P=.115)和亚裔(OR 1.13;95%CI 0.99-1.29;P=.074)患者接受近距离放射治疗的比例相似。
- 与私人保险患者相比,无保险(OR 0.72;95%CI 0.65-0.79;P<.001)、医疗补助(OR 0.83;95%CI 0.77-0.89;P<.001)和医疗保险(OR 0.85;95%CI 0.78-0.92;P<.001)患者更少接受近距离放射治疗。
- 近距离放射治疗未发现是种族和保险相关总生存差异的中介因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effects of race and insurance status on the use of brachytherapy for treatment of cervical cancer. METHODS: This is a retrospective cohort study of the National Cancer Database. We identified 25,223 patients diagnosed with stage IB2 through IVA cervical cancer who received radiation therapy during their primary treatment from 2004 to 2015. A univariate analysis was used to assess covariate association with brachytherapy. A multivariable regression model was used to evaluate the effect of race and insurance status on rates of brachytherapy treatment. The Cox proportional hazards model and the multiplicative hazard model were used to evaluate overall survival. P<.05 indicated a statistically significant difference for comparisons of primary and secondary outcomes. RESULTS: Non-Hispanic black patients received brachytherapy at a significantly lower rate than non-Hispanic white patients (odds ratio [OR] 0.93; 95% CI 0.86-0.99; P=.036); Hispanic (OR 0.93; 95% CI 0.85-1.02; P=.115) and Asian (OR 1.13; 95% CI 0.99-1.29; P=.074) patients received brachytherapy at similar rates. Compared with patients with private insurance, those who were uninsured (OR 0.72; 95% CI 0.65-0.79; P<.001), had Medicaid (OR 0.83; 95% CI 0.77-0.89; P<.001) or Medicare insurance (OR 0.85; 95% CI 0.78-0.92; P<.001) were less likely to receive brachytherapy. Brachytherapy was not found to be a mediator of race and insurance-related disparities in overall survival. CONCLUSION: Racial and insurance disparities exist for those who receive brachytherapy, with many patients not receiving the standard of care, but overall survival was not affected.
引用
- Bruce SF, Joshi TV, Chervoneva I, et al. Disparities Among Cervical Cancer Patients Receiving Brachytherapy. Obstet Gynecol. 2019. PMID: 31403593. doi:10.1097/AOG.0000000000003401
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。